Bavarian Nordic CEO Paul Chaplin discusses how expanded approval for its mpox vaccine could help groups most vulnerable to the latest mpox virus outbreak..
Back to Health Page
Bavarian Nordic CEO Paul Chaplin discusses how expanded approval for its mpox vaccine could help groups most vulnerable to the latest mpox virus outbreak.
Bavarian Nordic CEO Paul Chaplin discusses how expanded approval for its mpox vaccine could help groups most vulnerable to the latest mpox virus outbreak..
Back to Health Page
